HEALTHPEAK PROPERTIES INC (DOC) Fundamental Analysis & Valuation

NYSE:DOC • US42250P1030

Current stock price

16.17 USD
+0.18 (+1.13%)
At close:
16.18 USD
+0.01 (+0.06%)
After Hours:

This DOC fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

5

1. DOC Profitability Analysis

1.1 Basic Checks

  • In the past year DOC was profitable.
  • DOC had a positive operating cash flow in the past year.
  • DOC had positive earnings in each of the past 5 years.
  • In the past 5 years DOC always reported a positive cash flow from operatings.
DOC Yearly Net Income VS EBIT VS OCF VS FCFDOC Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 500M -500M 1B -1B

1.2 Ratios

  • DOC's Return On Assets of 0.35% is in line compared to the rest of the industry. DOC outperforms 46.28% of its industry peers.
  • The Return On Equity of DOC (0.94%) is comparable to the rest of the industry.
  • Looking at the Return On Invested Capital, with a value of 2.24%, DOC is in line with its industry, outperforming 40.50% of the companies in the same industry.
  • The Average Return On Invested Capital over the past 3 years for DOC is in line with the industry average of 3.11%.
Industry RankSector Rank
ROA 0.35%
ROE 0.94%
ROIC 2.24%
ROA(3y)1.17%
ROA(5y)1.99%
ROE(3y)2.87%
ROE(5y)4.76%
ROIC(3y)2.27%
ROIC(5y)2.16%
DOC Yearly ROA, ROE, ROICDOC Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5 10 15

1.3 Margins

  • DOC has a Profit Margin (2.50%) which is comparable to the rest of the industry.
  • In the last couple of years the Profit Margin of DOC has declined.
  • With a Operating Margin value of 19.31%, DOC perfoms like the industry average, outperforming 46.28% of the companies in the same industry.
  • DOC's Operating Margin has improved in the last couple of years.
  • DOC's Gross Margin of 60.00% is on the low side compared to the rest of the industry. DOC is outperformed by 67.77% of its industry peers.
  • DOC's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 19.31%
PM (TTM) 2.5%
GM 60%
OM growth 3Y0.32%
OM growth 5Y7.81%
PM growth 3Y-53.06%
PM growth 5Y-36.91%
GM growth 3Y1.1%
GM growth 5Y2.84%
DOC Yearly Profit, Operating, Gross MarginsDOC Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20 40 60 80

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

1

2. DOC Health Analysis

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), DOC is destroying value.
  • Compared to 1 year ago, DOC has less shares outstanding
  • Compared to 5 years ago, DOC has more shares outstanding
  • Compared to 1 year ago, DOC has a worse debt to assets ratio.
DOC Yearly Shares OutstandingDOC Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M
DOC Yearly Total Debt VS Total AssetsDOC Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5B 10B 15B 20B

2.2 Solvency

  • Based on the Altman-Z score of 0.30, we must say that DOC is in the distress zone and has some risk of bankruptcy.
  • The Altman-Z score of DOC (0.30) is comparable to the rest of the industry.
  • DOC has a Debt/Equity ratio of 1.27. This is a high value indicating a heavy dependency on external financing.
  • DOC has a Debt to Equity ratio of 1.27. This is comparable to the rest of the industry: DOC outperforms 47.93% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.27
Debt/FCF N/A
Altman-Z 0.3
ROIC/WACC0.37
WACC6.09%
DOC Yearly LT Debt VS Equity VS FCFDOC Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 2B 4B 6B 8B

2.3 Liquidity

  • DOC has a Current Ratio of 0.48. This is a bad value and indicates that DOC is not financially healthy enough and could expect problems in meeting its short term obligations.
  • DOC's Current ratio of 0.48 is on the low side compared to the rest of the industry. DOC is outperformed by 75.21% of its industry peers.
  • DOC has a Quick Ratio of 0.48. This is a bad value and indicates that DOC is not financially healthy enough and could expect problems in meeting its short term obligations.
  • Looking at the Quick ratio, with a value of 0.48, DOC is doing worse than 75.21% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.48
Quick Ratio 0.48
DOC Yearly Current Assets VS Current LiabilitesDOC Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. DOC Growth Analysis

3.1 Past

  • The earnings per share for DOC have decreased by 0.00% in the last year.
  • The earnings per share for DOC have been decreasing by -16.06% on average. This is quite bad
  • The Revenue has been growing slightly by 4.52% in the past year.
  • Measured over the past years, DOC shows a quite strong growth in Revenue. The Revenue has been growing by 11.40% on average per year.
EPS 1Y (TTM)0%
EPS 3Y-27.44%
EPS 5Y-16.06%
EPS Q2Q%1500%
Revenue 1Y (TTM)4.52%
Revenue growth 3Y11.05%
Revenue growth 5Y11.4%
Sales Q2Q%3.07%

3.2 Future

  • The Earnings Per Share is expected to grow by 0.77% on average over the next years.
  • Based on estimates for the next years, DOC will show a small growth in Revenue. The Revenue will grow by 5.62% on average per year.
EPS Next Y-37.96%
EPS Next 2Y-16.2%
EPS Next 3Y-9.72%
EPS Next 5Y0.77%
Revenue Next Year3.34%
Revenue Next 2Y4.41%
Revenue Next 3Y4.42%
Revenue Next 5Y5.62%

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
DOC Yearly Revenue VS EstimatesDOC Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 1B 2B 3B 4B
DOC Yearly EPS VS EstimatesDOC Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 0.5 1 1.5 2

More info and screens

Find the best growth stocksShow best growing peers

1

4. DOC Valuation Analysis

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 46.20, the valuation of DOC can be described as expensive.
  • The rest of the industry has a similar Price/Earnings ratio as DOC.
  • DOC is valuated expensively when we compare the Price/Earnings ratio to 26.77, which is the current average of the S&P500 Index.
  • Based on the Price/Forward Earnings ratio of 74.46, the valuation of DOC can be described as expensive.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of DOC is on the same level as its industry peers.
  • DOC is valuated expensively when we compare the Price/Forward Earnings ratio to 21.75, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 46.2
Fwd PE 74.46
DOC Price Earnings VS Forward Price EarningsDOC Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, DOC is valued a bit cheaper than the industry average as 64.46% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 12.78
DOC Per share dataDOC EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6 8 10

4.3 Compensation for Growth

  • DOC's earnings are expected to decrease with -9.72% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-16.2%
EPS Next 3Y-9.72%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

5

5. DOC Dividend Analysis

5.1 Amount

  • With a Yearly Dividend Yield of 7.63%, DOC is a good candidate for dividend investing.
  • DOC's Dividend Yield is rather good when compared to the industry average which is at 7.44. DOC pays more dividend than 80.17% of the companies in the same industry.
  • Compared to an average S&P500 Dividend Yield of 1.82, DOC pays a better dividend.
Industry RankSector Rank
Dividend Yield 7.63%

5.2 History

  • The dividend of DOC decreases each year by -4.20%.
  • DOC has been paying a dividend for at least 10 years, so it has a reliable track record.
Dividend Growth(5Y)-4.2%
Div Incr Years0
Div Non Decr Years0
DOC Yearly Dividends per shareDOC Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0.5 1 1.5 2 2.5

5.3 Sustainability

  • DOC pays out 1204.15% of its income as dividend. This is not a sustainable payout ratio.
DP1204.15%
EPS Next 2Y-16.2%
EPS Next 3Y-9.72%
DOC Yearly Income VS Free CF VS DividendDOC Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 500M -500M 1B -1B
DOC Dividend Payout.DOC Dividend Payout, showing the Payout Ratio.DOC Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

DOC Fundamentals: All Metrics, Ratios and Statistics

HEALTHPEAK PROPERTIES INC

NYSE:DOC (4/30/2026, 7:40:30 PM)

After market: 16.18 +0.01 (+0.06%)

16.17

+0.18 (+1.13%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryDiversified REITs
Industry Strength71.43
Industry Growth65.22
Earnings (Last)04-22
Earnings (Next)07-22
Inst Owners97.77%
Inst Owner Change0.01%
Ins Owners0.23%
Ins Owner Change1.26%
Market Cap11.24B
Revenue(TTM)2.82B
Net Income(TTM)70.51M
Analysts73.91
Price Target19.59 (21.15%)
Short Float %4.62%
Short Ratio3.96
Dividend
Industry RankSector Rank
Dividend Yield 7.63%
Yearly Dividend1.22
Dividend Growth(5Y)-4.2%
DP1204.15%
Div Incr Years0
Div Non Decr Years0
Ex-Date06-15
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)108.65%
Min EPS beat(2)37.75%
Max EPS beat(2)179.54%
EPS beat(4)3
Avg EPS beat(4)52.57%
Min EPS beat(4)-19.41%
Max EPS beat(4)179.54%
EPS beat(8)5
Avg EPS beat(8)31.44%
EPS beat(12)8
Avg EPS beat(12)38.23%
EPS beat(16)11
Avg EPS beat(16)56.93%
Revenue beat(2)2
Avg Revenue beat(2)1.99%
Min Revenue beat(2)0.94%
Max Revenue beat(2)3.04%
Revenue beat(4)3
Avg Revenue beat(4)1.41%
Min Revenue beat(4)-0.37%
Max Revenue beat(4)3.04%
Revenue beat(8)7
Avg Revenue beat(8)2.35%
Revenue beat(12)9
Avg Revenue beat(12)-4.49%
Revenue beat(16)11
Avg Revenue beat(16)-3.26%
PT rev (1m)-0.48%
PT rev (3m)-2.13%
EPS NQ rev (1m)-8.33%
EPS NQ rev (3m)-12%
EPS NY rev (1m)0%
EPS NY rev (3m)-17.76%
Revenue NQ rev (1m)1.3%
Revenue NQ rev (3m)0.82%
Revenue NY rev (1m)1.37%
Revenue NY rev (3m)1.95%
Valuation
Industry RankSector Rank
PE 46.2
Fwd PE 74.46
P/S 3.98
P/FCF N/A
P/OCF 8.98
P/B 1.5
P/tB 1.66
EV/EBITDA 12.78
EPS(TTM)0.35
EY2.16%
EPS(NY)0.22
Fwd EY1.34%
FCF(TTM)-0.19
FCFYN/A
OCF(TTM)1.8
OCFY11.14%
SpS4.06
BVpS10.79
TBVpS9.75
PEG (NY)N/A
PEG (5Y)N/A
Graham Number9.2169 (-43%)
Profitability
Industry RankSector Rank
ROA 0.35%
ROE 0.94%
ROCE 2.84%
ROIC 2.24%
ROICexc 2.3%
ROICexgc 2.51%
OM 19.31%
PM (TTM) 2.5%
GM 60%
FCFM N/A
ROA(3y)1.17%
ROA(5y)1.99%
ROE(3y)2.87%
ROE(5y)4.76%
ROIC(3y)2.27%
ROIC(5y)2.16%
ROICexc(3y)2.3%
ROICexc(5y)2.18%
ROICexgc(3y)2.51%
ROICexgc(5y)2.37%
ROCE(3y)2.87%
ROCE(5y)2.73%
ROICexgc growth 3Y5.01%
ROICexgc growth 5Y15.76%
ROICexc growth 3Y4.44%
ROICexc growth 5Y15.37%
OM growth 3Y0.32%
OM growth 5Y7.81%
PM growth 3Y-53.06%
PM growth 5Y-36.91%
GM growth 3Y1.1%
GM growth 5Y2.84%
F-Score6
Asset Turnover0.14
Health
Industry RankSector Rank
Debt/Equity 1.27
Debt/FCF N/A
Debt/EBITDA 5.92
Cap/Depr 130.74%
Cap/Sales 49.05%
Interest Coverage 2.1
Cash Conversion 78.06%
Profit Quality N/A
Current Ratio 0.48
Quick Ratio 0.48
Altman-Z 0.3
F-Score6
WACC6.09%
ROIC/WACC0.37
Cap/Depr(3y)104.54%
Cap/Depr(5y)153.18%
Cap/Sales(3y)38.39%
Cap/Sales(5y)55.21%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)0%
EPS 3Y-27.44%
EPS 5Y-16.06%
EPS Q2Q%1500%
EPS Next Y-37.96%
EPS Next 2Y-16.2%
EPS Next 3Y-9.72%
EPS Next 5Y0.77%
Revenue 1Y (TTM)4.52%
Revenue growth 3Y11.05%
Revenue growth 5Y11.4%
Sales Q2Q%3.07%
Revenue Next Year3.34%
Revenue Next 2Y4.41%
Revenue Next 3Y4.42%
Revenue Next 5Y5.62%
EBIT growth 1Y-3.69%
EBIT growth 3Y11.4%
EBIT growth 5Y20.1%
EBIT Next Year256.58%
EBIT Next 3Y59.69%
EBIT Next 5Y35.87%
FCF growth 1Y-137.77%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y16.95%
OCF growth 3Y11.62%
OCF growth 5Y10.54%

HEALTHPEAK PROPERTIES INC / DOC Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for HEALTHPEAK PROPERTIES INC?

ChartMill assigns a fundamental rating of 3 / 10 to DOC.


What is the valuation status for DOC stock?

ChartMill assigns a valuation rating of 1 / 10 to HEALTHPEAK PROPERTIES INC (DOC). This can be considered as Overvalued.


How profitable is HEALTHPEAK PROPERTIES INC (DOC) stock?

HEALTHPEAK PROPERTIES INC (DOC) has a profitability rating of 5 / 10.


Can you provide the financial health for DOC stock?

The financial health rating of HEALTHPEAK PROPERTIES INC (DOC) is 1 / 10.


Is the dividend of HEALTHPEAK PROPERTIES INC sustainable?

The dividend rating of HEALTHPEAK PROPERTIES INC (DOC) is 5 / 10 and the dividend payout ratio is 1204.15%.